Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patterns of Care for Adults With Malignant Glioma—Reply

Patterns of Care for Adults With Malignant Glioma—Reply In Reply: As a multidisciplinary group of investigators, some of whom began our careers in palliative care, we agree that the issues Dr Shannon and colleagues raise, such as relief of common symptoms like fatigue or cognitive deficits, as well as medical and psychosocial support to improve quality of life, are of critical importance to patients with brain tumors throughout their entire illness. Whether trained as surgeons, neurologists, or medical or radiation oncologists, clinicians who care for patients with brain tumors should all receive instruction in these basic principles of palliative care that are central to the care of all patients and should be familiar to all physicians.1 The declared specialty of the physician providing these aspects of care seems less important, since patients with brain tumors receive their primary treatment from members of several specialties during the course of their disease. We agree that research into symptom palliation for patients with brain tumors is a pressing need,2 and the Glioma Outcomes Project has already investigated aspects of palliative care such as depression3 in addition to those addressed in our article. Back to top Article Information Financial Disclosures: Under separate licensing agreements between the Johns Hopkins University and Guilford Pharmaceuticals Inc and the Johns Hopkins University and Angiotech Pharmaceuticals Inc, Dr Brem is entitled to a share of royalty received by the university on sales of products described in the research article. Dr Brem owns Guilford Pharmaceuticals stock, which is subject to certain restrictions under university policy. Dr Brem is also a paid consultant to Guilford Pharmaceuticals. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. No other authors reported financial disclosures. References 1. Stevens LM, Lynm C, Glass RM. Palliative care [JAMA Patient Page]. JAMA. 2005;293:141015769975Google ScholarCrossref 2. Taillibert S, Laigle-Donadey F, Sanson M. Palliative care in patients with primary brain tumors. Curr Opin Oncol. 2004;16:587-59215627022Google ScholarCrossref 3. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr.Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-36614744282Google ScholarCrossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Patterns of Care for Adults With Malignant Glioma—Reply

Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/patterns-of-care-for-adults-with-malignant-glioma-reply-8541AfVfi3

References (3)

Publisher
American Medical Association
Copyright
Copyright © 2005 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.293.20.2470
Publisher site
See Article on Publisher Site

Abstract

In Reply: As a multidisciplinary group of investigators, some of whom began our careers in palliative care, we agree that the issues Dr Shannon and colleagues raise, such as relief of common symptoms like fatigue or cognitive deficits, as well as medical and psychosocial support to improve quality of life, are of critical importance to patients with brain tumors throughout their entire illness. Whether trained as surgeons, neurologists, or medical or radiation oncologists, clinicians who care for patients with brain tumors should all receive instruction in these basic principles of palliative care that are central to the care of all patients and should be familiar to all physicians.1 The declared specialty of the physician providing these aspects of care seems less important, since patients with brain tumors receive their primary treatment from members of several specialties during the course of their disease. We agree that research into symptom palliation for patients with brain tumors is a pressing need,2 and the Glioma Outcomes Project has already investigated aspects of palliative care such as depression3 in addition to those addressed in our article. Back to top Article Information Financial Disclosures: Under separate licensing agreements between the Johns Hopkins University and Guilford Pharmaceuticals Inc and the Johns Hopkins University and Angiotech Pharmaceuticals Inc, Dr Brem is entitled to a share of royalty received by the university on sales of products described in the research article. Dr Brem owns Guilford Pharmaceuticals stock, which is subject to certain restrictions under university policy. Dr Brem is also a paid consultant to Guilford Pharmaceuticals. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. No other authors reported financial disclosures. References 1. Stevens LM, Lynm C, Glass RM. Palliative care [JAMA Patient Page]. JAMA. 2005;293:141015769975Google ScholarCrossref 2. Taillibert S, Laigle-Donadey F, Sanson M. Palliative care in patients with primary brain tumors. Curr Opin Oncol. 2004;16:587-59215627022Google ScholarCrossref 3. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr.Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-36614744282Google ScholarCrossref

Journal

JAMA – American Medical Association

Published: May 25, 2005

There are no references for this article.